Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Community health workers may cut epilepsy ER visits for underserved patients

NCT ID NCT07663240

Disease control Sponsor: Morehouse School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program where community health workers help adults with epilepsy who frequently visit the emergency room. Over 9 to 12 months, the health workers provide home visits and phone support to help with medication, seizure tracking, and connecting to doctors. The goal is to see if this support reduces emergency visits and improves seizure control and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
community health worker-led transition-of-care intervention
What this could lead to
If successful, this program could reduce unnecessary emergency visits and improve quality of life for underserved adults with epilepsy.
What could go wrong
This is a small, early-stage study with only 15 participants, so results may not apply broadly. The program's success depends on individual engagement and available resources.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult women with a confirmed diagnosis of epilepsy who are high utilizers of emergency department services at Grady Health System. Participants are enrolled through the Transition of Care (TOC) ED High Utilizer Program and have a history of frequent seizure-related ED visits. The study focuses on Black and Hispanic women residing in the Atlanta metropolitan area.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult women aged 18 years or older * Confirmed diagnosis of epilepsy documented in the electronic health record (EHR) * Enrolled in the Grady Health System Transition of Care (TOC) ED High Utilizer Program * History of three or more seizure-related emergency department visits within the past 12 months * Self-identify as Black or Hispanic * Reside in the Atlanta metropolitan area with intent to remain for at least 12 months * Have access to a working phone for follow-up communication Exclusion Criteria: * No confirmed epilepsy diagnosis (e.g., non-epileptic seizures) * Younger than 18 years of age * Not identified as a high ED utilizer for seizure-related care * Unable to provide informed consent due to cognitive impairment or psychiatric instability * Regularly taking anti-epileptic medications with established adherence * Scheduled neurology follow-up within 14 days of discharge or consistent primary care follow-up * Complex medical conditions that would limit participation in outpatient follow-up * Non-English speaking * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy Uncontrolled seizures

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Morehouse School of Medicine

    Atlanta, Georgia, 30310, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.